SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Neoforma Inc, et al. – ‘SC 13E3/A’ on 1/4/06 re: Neoforma Inc – EX-99.(C)(3)

On:  Wednesday, 1/4/06, at 4:47pm ET   ·   Accession #:  1193125-6-1077   ·   File #:  5-58839

Previous ‘SC 13E3’:  ‘SC 13E3’ on 11/10/05   ·   Next:  ‘SC 13E3/A’ on 1/18/06   ·   Latest:  ‘SC 13E3/A’ on 1/23/06

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/04/06  Neoforma Inc                      SC 13E3/A              3:1.7M Neoforma Inc                      RR Donnelley/FA
          Global Healthcare Exchange, LLC
          University Healthsystem Consortium
          Vha Inc

Amendment to Tender-Offer Statement — Going-Private Transaction   —   Schedule 13E-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13E3/A   Amendment No. 1 to Schedule 13E-3                   HTML    262K 
 2: EX-99.(C)(3)  Preliminary Presentation of Merill Lynch,         HTML    106K 
                          Pierce, Fenner & Smith- 08/29/05                       
 3: EX-99.(C)(4)  Preliminary Presentation of Merrill Lynch,        HTML    179K 
                          Pierce, Fenner & Smith- 08/05/05                       


EX-99.(C)(3)   —   Preliminary Presentation of Merill Lynch, Pierce, Fenner & Smith- 08/29/05


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Preliminary presentation of Merill Lynch, Pierce, Fenner & Smith- 08/29/05  
Neoforma Special Committee
Confidential Presentation Materials Prepared For:
Regarding
Project LeapFrog
DRAFT
Exhibit (c)(3)


DRAFT
Preliminary Valuation


CONFIDENTIAL
DRAFT
1
Preliminary Valuation
Neoforma Operating Environment Overview
VUN approach to Marketplace@ Novation and relationship with Neoforma has changed materially
VUN has changed its e-commerce strategy to “low cost”
from “highly differentiated”
Certain Neoforma offerings (e.g., Spend Intelligence) now perceived as competitive to VUN
Change in VUN appears to be driven by GPO competitive landscape and resultant change in
underlying VUN business strategy
Unclear whether VUN remains desirous of any ongoing relationship
with Neoforma
Revenue from core M@N business likely to fall under renegotiated
contract or benchmarking
VUN committed to achieving $15 -
$25mm drop in fee
Benchmarking theoretically could keep $61mm level, but VUN unlikely to renew upon
contract expiration in March 2010 and operating dynamic would be
difficult
Ability
to
utilize
member-based
pricing
to
overcome
OA
fee
reduction
doubtful
given current
VUN mindset


CONFIDENTIAL
DRAFT
2
Preliminary Valuation
Neoforma Operating Environment Overview (cont’d)
Value of VUN relationship and channel declining
Primary growth avenue –
ability to leverage channel –
is now questionable (e.g., new
developments re competitive nature of Spend Intelligence)
Supplier adoption difficult with VUN relationship in place
Prior
base
case
NSG
projections
(30%
CAGR
2005-2010)
now
appear
very
aggressive
GHX in strong position to aggressively compete with Neoforma in all areas under status quo
scenario
Benefit of full company due diligence (products, services, future development, strategy,
customer lists, weaknesses, etc.) and intimate knowledge of VUN
Ability of Neoforma to succeed given current VUN mindset and desired control questionable
Financial projections exercise challenging given role and rights
of VUN
Impossible to predict outcome of negotiations with VUN or benchmarking process
Impossible to predict NSG revenue growth absent discussions with
VUN


CONFIDENTIAL
DRAFT
3
Preliminary Valuation
We have analyzed three primary scenarios with respect to the Outsourcing Agreement
Scenario
1:
Contract
Terminated
in
2010
The OA is assumed to remain in place, but is not extended at its termination in 2010
$37 -
$61mm revenue per year from OA
Only NSG business continues
Scenario
2:
Contract
Extended
through
2015
The OA is renegotiated effective January 2006, and is assumed to be extended through
2015 (feasibility of this unclear); OA is not extended beyond this point
$37 -
$49mm revenue per year from OA
Only NSG business continues
Scenario
3:
Contract
Renewed
in
Perpetuity
The OA is renegotiated effective January 2006 and is assumed to
be extended in
perpetuity (feasibility of this unclear) at 0% growth
$37 -
$49mm revenue per year from OA
OA and NSG business continue
The
cost
structure
is
sensitized
to
OA
revenue
below
$49mm
of
OA
revenue,
gross
operating
costs
decrease ~$1mm for each $4mm drop in revenue as the number of employees required to service the
contract decreases
Above
$49mm
of
OA
revenue,
the
cost
structure
is
assumed
to
remain
unchanged
a
$1mm
increase in OA fee above $49mm results in a $1mm increase in EBITDA
Scenario Analysis


CONFIDENTIAL
DRAFT
4
Preliminary Valuation
Key Model Assumptions
Source: Management
Flat OA revenue growth
MMS business (provider & supplier) is divested
Move to new facility at 4/1/07 or earlier at a significantly reduced cost
No Ideal or Inobis transaction
Plan B implementation including:
Management reduction
Modesto PDS
Modesto CSS
Expense assumptions are per management
Use of outsourced contract workers falls as OA revenue falls
Scenario 1 assumes the OA contract expires in March of 2010 –
only one quarter of revenue is
realized
All
but
$12mm
of
the
full
year’s
projected
gross
operating
costs
remain
Base Case Projections through 2008E


CONFIDENTIAL
DRAFT
5
Preliminary Valuation
Key Model Assumptions
NSG revenues are projected using a 20% growth rate in 2009E and 2010E (yielding CAGR of
30% for 2005-2010 NSG revenue growth) and 10% beyond 2010E
Given current discussions with VUN re Spend Intelligence, this is now aggressive
Projected consolidated EBITDA margin assumed to remain flat at 2008E level
Gross operating expenses and capitalized software costs flat at 2008E percent of sales
Capital expenditures projected at 4.0% of sales (based on 2006E –
2008E average)
Change in net working capital held flat at 2008E level (-$3.3 million)
For Scenarios 1 and 2, Perpetuity Value is derived entirely from
NSG business
NSG EBITDA margin assumed to be 10.0% (business burdened by entire corporate
overhead and public company costs)
For analysis of Scenario 2, we have extended projections through
2015
NSG revenues are projected using a 10% growth rate in 2011E through 2015E
Base Case Projections beyond 2008E


CONFIDENTIAL
DRAFT
Valuation
based
on
Discounted
Cash
Flow
analysis
of
2006
2010
(or
through
2015),
including sensitivity to
changes in the OA revenue, as of 9/30/05 using mid- year convention at discount rate of 14%
Terminal Value calculated using two methods:
Blended Perpetuity growth rate of 3.0% to 5.0% on continuing cash flows
LTM EBITDA exit multiple of 10.0x to 12.0x on continuing EBITDA
Operating cash flows are not tax-effected due to utilization of NOL
Perpetuity cash flows are taxed at 35%
Assumes
$39.1mm
of
cash
as
of
9/30/05,
$3.9mm
cash
restructuring
costs,
and
20.7mm
shares outstanding
6
Preliminary Valuation
Valuation Methodology
Indicative Cash Flows –
$49mm OA Fee
Fiscal Year Ended
2006
2007
2008
2009
2010
Revenue
$66.1
$71.8
$80.1
$86.3
$93.8
   Y-o-Y growth %
(10.2%)
8.6%
11.6%
7.7%
8.6%
EBITDA
$12.4
$20.5
$24.9
$26.8
$29.1
   Margin %
18.7%
28.5%
31.0%
31.0%
31.0%
Less: changes in working capital
(3.6)
(0.8)
(3.3)
(3.3)
(3.3)
Less: capital expenditure
(3.0)
(5.0)
(3.0)
(3.5)
(3.8)
Capitalization of SW Development
(4.9)
(5.9)
(5.9)
(6.4)
(6.9)
Unlevered Free Cash Flow
$0.8
$8.8
$12.6
$13.6
$15.1
Free Cash Flow Growth Rate
(93.5%)
975.3%
43.5%
8.0%
10.7%
____________________
(1)
Untaxed cash flow from continuing operations.  For valuation purposes, taxed at 35% in perpetuity.
(1)


CONFIDENTIAL
DRAFT
7
Discounted
Cash
Flow
Sensitivity
Analysis
Preliminary Valuation
Scenario 1 –
Contract Terminated in 2010
____________________
(1)   
Equity
Value
=
Enterprise
Value
+
Net
Cash
Severance
and
other
one-time
costs
of
$3.9mm.
(2)
Assumes NSG 2005-2010 revenue CAGR of 30%.
Midpoint of 3.0% to 5.0% Growth Rate
$37.0
$45.0
$50.0
$55.0
$61.0
13.0%
2.01
2.74
3.23
3.92
4.74
14.0%
1.94
2.64
3.13
3.80
4.59
15.0%
1.88
2.57
3.04
3.69
4.47
Value Per Share -
Perpetuity Method
(1) (2)
Novation
Annual Revenue -
'06 and forward
Midpoint of 10x to 12x LTM EBITDA Multiple
$37.0
$45.0
$50.0
$55.0
$61.0
13.0%
2.69
3.43
3.94
4.64
5.47
14.0%
2.64
3.36
3.86
4.54
5.34
15.0%
2.59
3.29
3.78
4.44
5.22
Value Per Share -
EBITDA Method
(1) (2)
Novation
Annual Revenue -
'06 and forward


CONFIDENTIAL
DRAFT
8
Discounted
Cash
Flow
Sensitivity
Analysis
Preliminary Valuation
Scenario 2 –
Contract Extended through 2015
____________________
(1)     Equity
Value
=
Enterprise
Value
+
Net
Cash
Severance
and
other
one-time
costs
of
$3.9mm.
(2)
Assumes NSG 2005-2010 revenue CAGR of 30%.
Value Per Share -
Perpetuity Method
(1) (2)
Midpoint of 3.0% to 5.0% Growth Rate
Novation
Annual Revenue -
'06 and forward
4.9
$37.0
$41.0
$45.0
$49.0
13.0%
3.04
3.76
4.48
5.19
14.0%
2.88
3.57
4.25
4.93
15.0%
2.75
3.40
4.06
4.70
Value Per Share -
EBITDA Method
(1) (2)
Midpoint of 10x to 12x LTM EBITDA Multiple
Novation
Annual Revenue -
'06 and forward
5.5
$37.0
$41.0
$45.0
$49.0
13.0%
3.57
4.30
5.02
5.73
14.0%
3.42
4.11
4.80
5.48
15.0%
3.28
3.94
4.59
5.24


CONFIDENTIAL
DRAFT
9
Discounted
Cash
Flow
Sensitivity
Analysis
Preliminary Valuation
Scenario 3 –
Contract Renewed in Perpetuity
____________________
(1)     Equity
Value
=
Enterprise
Value
+
Net
Cash
Severance
and
other
one-time
costs
of
$3.9mm.
(2)
Assumes NSG 2005-2010 revenue CAGR of 30%.
Value Per Share -
Perpetuity Method
(1) (2)
Midpoint of 3.0% to 5.0% Growth Rate
Novation
Annual Revenue -
'06 and forward
$37.0
$41.0
$45.0
$49.0
13.0%
3.01
4.03
5.03
6.02
14.0%
2.83
3.75
4.66
5.56
15.0%
2.69
3.53
4.36
5.19
Value Per Share -
EBITDA Method
(1) (2)
Midpoint of 10x to 12x LTM EBITDA Multiple
Novation
Annual Revenue -
'06 and forward
$37.0
$41.0
$45.0
$49.0
13.0%
5.41
6.73
8.04
9.34
14.0%
5.24
6.51
7.76
9.00
15.0%
5.07
6.29
7.49
8.69

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC 13E3/A’ Filing    Date    Other Filings
Filed on:1/4/068-K,  PRER14A
8/29/05
 List all Filings 
Top
Filing Submission 0001193125-06-001077   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 6:21:30.2pm ET